According to official media sources, quoted by The Washington Post, leading Chinese epidemiologist Zhong Nanshan on Monday said that two new vaccinations for the XBB omicron subvariants (including XBB. 1.9.1, XBB. 1.5, and XBB. 1.16) have been given preliminary approval.
